(Q53015060)

10 May 2018

title

Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. (English)

1 reference

10 May 2018

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

1 reference

3

1 reference

10 May 2018

author name string

Sechang Oh

1

1 reference

10 May 2018

Takashi Shida

2

1 reference

10 May 2018

Kiyoji Tanaka

4

1 reference

10 May 2018

Rina So

5

1 reference

10 May 2018

Takehiko Tsujimoto

6

1 reference

10 May 2018

Junichi Shoda

7

1 reference

10 May 2018

language of work or name

English

0 references

publication date

17 February 2015

1 reference

10 May 2018

published in

Hepatology

1 reference

10 May 2018

volume

61

1 reference

10 May 2018

issue

4

1 reference

10 May 2018

page(s)

1205-1215

1 reference

10 May 2018

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

cites work

1 reference

Non-alcoholic fatty liver disease: current concepts and management strategies.

21 January 2018

1 reference

Benefits of lifestyle modification in NAFLD.

21 January 2018

1 reference

Does physical inactivity cause nonalcoholic fatty liver disease?

21 January 2018

1 reference

Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults

21 January 2018

1 reference

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

21 January 2018

1 reference

Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease

21 January 2018

1 reference

Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?

21 January 2018

1 reference

Criteria and classification of obesity in Japan and Asia-Oceania.

21 January 2018

1 reference

Psychophysical bases of perceived exertion

21 January 2018

1 reference

The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry.

21 January 2018

1 reference

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

21 January 2018

1 reference

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

21 January 2018

1 reference

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles.

21 January 2018

1 reference

Inflammation and metabolic disorders

21 January 2018

1 reference

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

Role of Nrf2 in oxidative stress and toxicity

21 January 2018

1 reference

Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide

21 January 2018

1 reference

Non-alcoholic fatty liver disease and the metabolic syndrome: an update

21 January 2018

1 reference

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

21 January 2018

1 reference

Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

Exercise and the liver: implications for therapy in fatty liver disorders

21 January 2018

1 reference

American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise

21 January 2018

1 reference

American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults

21 January 2018

1 reference

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Exercise reduces inflammation and oxidative stress in obesity-related liver diseases

1 reference

7 January 2021

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

7 January 2021

Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)

1 reference

7 January 2021

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27544

1 reference

10 May 2018

PubMed ID

25271091

1 reference

10 May 2018